Lacosamide Oral Solution — Class II drug recall D-0457-2025
Ongoing recall by Apotex Corp., reported 2025-06-11, distributed nationwide. Defective Container: This recall is being initiated due to a leaking unit stored horizontally.
| Recall number | D-0457-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Apotex Corp., Weston, FL, United States |
| Recall initiated | 2025-05-28 |
| Classified | 2025-06-03 |
| Reported by FDA | 2025-06-11 |
| Distributed | Nationwide (US) |
| Quantity | 20,648 bottles |
| Reason classes | packaging |
| NDC | 60505-0405-04 |
| Lot numbers | TZ5589 |
| Expiration dates | 2026-01-31 |
Product
Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston FL 33326, NDC 60505-0405-4
Reason for recall
Defective Container: This recall is being initiated due to a leaking unit stored horizontally.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0457-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.